Работы, на которые ссылается эта работа

Работ: 196

Работа: Advancing the global public health agenda for NAFLD: a consensus statement

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Theo Vos, Stephen S Lim, Cristiana Abbafati +97
СтатьяGlobal Maternal and Child HealthThe Lancet2020Цитирований: 12
ABI
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
Zobair M. Younossi, Aaron B. Koenig, Dinan Abdelatif +3
Обзорная статья2015Цитирований: 7
ABI
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani, Zobair M. Younossi, Joel E. Lavine +6
Обзорная статья2017Цитирований: 5
ABI
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Sadaf G Sepanlou, Saeid Safiri, Catherine Bisignano +97
Статья2020Цитирований: 5
ABI
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
Christina Fitzmaurice, Christine A. Allen, Ryan M Barber +97
СтатьяGlobal Cancer Incidence and ScreeningJAMA Oncology2016Цитирований: 4
ABI
NAFLD: A multisystem disease
Christopher D. Byrne, Giovanni Targher
Обзорная статья2015Цитирований: 4
ABI
Joint international consensus statement for ending stigma of obesity
Francesco Rubino, Rebecca M. Puhl, David E. Cummings +33
Обзорная статья2020Цитирований: 4
ABI
NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4
James E. Bennett, Gretchen A Stevens, Colin Mathers +15
СтатьяGlobal Public Health Policies and EpidemiologyThe Lancet2018Цитирований: 3
ABI
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
Nicholas R. Fuller, Stephen Colagiuri, Deborah Schofield +9
Статья2012Цитирований: 3
ABI
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Michael D. Jensen, Donna H. Ryan, Caroline M. Apovian +16
Статья2013Цитирований: 3
ABI
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Michael D. Jensen, Donna H. Ryan, Caroline M. Apovian +16
Статья2013Цитирований: 3
ABI
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair M. Younossi, Quentin M. Anstee, M. Marietti +5
Обзорная статья2017Цитирований: 3
ABI
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Статья2016Цитирований: 3
ABI
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017
Christina Fitzmaurice, Degu Abate, Naghmeh Abbasi +97
СтатьяGlobal Cancer Incidence and ScreeningJAMA Oncology2019Цитирований: 2
ABI
Expanding consensus in portal hypertension
Roberto de Franchis
Статья2015Цитирований: 2
ABI
Imaging approach in radioimmunodetection.
Frank H. DeLand, E. Edmund Kim, Guy Simmons +1
Статья1980Цитирований: 2
ABI
The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis
Emma L. Anderson, Laura D Howe, Hayley E Jones +3
Обзорная статья2015Цитирований: 2
ABI
Stigma, social inequality and alcohol and drug use
Robin Room
Обзорная статья2005Цитирований: 2
ABI
Prevalence of Fatty Liver in Children and Adolescents
Jeffrey B. Schwimmer, Reena Deutsch, Tanaz Kahen +3
Статья2006Цитирований: 2
ABI
Obesity Stigma: Important Considerations for Public Health
Rebecca M. Puhl, Chelsea A. Heuer
Статья2010Цитирований: 2
ABI
The Natural Course of Non-Alcoholic Fatty Liver Disease
Luis Calzadilla Bertot, Leon A. Adams
Обзорная статья2016Цитирований: 2
ABI
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Zobair M. Younossi, Deirdre B Blissett, Robert Blissett +6
Статья2016Цитирований: 2
ABI
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Chris Estes, Homie Razavi, Rohit Loomba +2
Обзорная статья2017Цитирований: 2
ABI
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
Fasiha Kanwal, Jennifer R. Kramer, Srikar Mapakshi +9
Статья2018Цитирований: 2
ABI
The role of nutrition in non‐alcoholic fatty liver disease: Pathophysiology and management
Genoveva Berná, Manuel Romero‐Gómez
Обзорная статья2020Цитирований: 2
ABI